Alzheimer'sCareDementiaHealthHealthcareHighlightsNewsResearch

Scottish Researchers Awarded £100k To Drive Forward A Cure For Dementia

Researchers based at leading Scottish Universities have received support from Alzheimer’s Research UK, helping them to develop future treatments for dementia.

The £100k is part of a £4 million funding announcement that will help UK researchers find new ways to treat, diagnose and prevent dementia. Over the last two decades, Alzheimer’s Research UK has provided over £10m of funding to dementia research in Scotland.

Dr Shuzo Sakata, based at the University of Strathclyde has been awarded £70K to understand more about the link between sleep and Alzheimer’s disease, in the hope of finding new ways to prevent the disease.

Research has shown that changes in sleep patterns are common in people with dementia, even in its early stages. However, the connection between sleep and dementia is still a mystery.

Speaking about the project Dr Sakata says:
“My project will hopefully shed light on how sleep affects the brain’s immune cells in Alzheimer’s. It’s the first time this will be studied and could help find new ways to treat and prevent Alzheimer’s disease in the future, which is an incredibly exciting prospect”.

Dr Paula Beltran-Lobo, based at the University of Edinburgh, has received £30K to investigate how the protective blood brain barrier becomes damaged by the diseases that cause dementia. The blood brain barrier controls the brain’s blood supply and regulates which substances cross it.

She will be focusing on star-shaped cells called astrocytes, which support the blood brain barrier and keep it healthy. But when a protein called tau builds up in astrocytes in diseases such as Alzheimer’s and Frontotemporal dementia, it can interfere with their function. This affect on the astrocytes can lead to the blood brain barrier becoming ‘leaky’.

Dr Beltran-Lobo said:
“By figuring out how the communication between astrocytes and the blood brain barrier becomes disrupted by tau, we may uncover key proteins that we can target with drugs. This funding provides a stepping stone for my research, which I hope will lead to the development of treatments which target earlier stages of the disease.”

Dr Julia Dudley, Head of Strategic Programmes at Alzheimer’s Research UK says:
“In the UK alone, nearly one million people are living with dementia. So there’s never been a more pressing need to prevent or treat the diseases that cause this devastating condition.

“Alzheimer’s Research UK is proud to support research that’s gaining a greater understanding of how these diseases develop in the brain which could lead to the breakthroughs that people with dementia deserve and need.

“It’s essential that we keep investing in studies like these to accelerate progress towards a cure, and to end the fear, harm and heartbreak from dementia.”

 

 
Advanced

 

 

 
carebeans

 

 

Nestle

 

 

CareShowLondon
 

 

 

 
COTS 2024

 

 

 
AccessGroup
 

 

 

Intracare